Benefits of new tools in biotechnology to developing countries in south Asia: a perspective from UNESCO

South Asia, once considered as a laggard, has grown at about 6% on average over the past two decades and the current growth outlook is much brighter. However, this growth is not always well distributed and the challenges of institutionalising policies and mechanisms to ensure inclusive growth are now being seriously considered by these countries governments. The targets set by south Asian countries are primarily based on the investments in infrastructural sector with an objective to generate educated and skilled human resources. The other most important inclusive growth area is the core public services; Agriculture, Health, and Energy, which are increasingly becoming technology driven. Biotechnology has been increasingly seen now to be an area of technology that holds the greatest new potential to address problems arising from low productivity, overburdened health systems, high-cost unsustainable energy supplies and the need for developing new materials for industrial and environmental applications. This article attempts to highlight perspectives on some of the emerging areas of biotechnology that have good potential for economic development in the context of south Asia, as well as discuss briefly some of UNESCO's initiatives in biotechnology for that region.     

Microorganisms under high pressure — Adaptation,growth and biotechnological potential

Hydrostatic pressure is a well-known physical parameter which is now considered an important variable of life, since organisms have the ability to adapt to pressure changes, by the development of resistance against this variable. In the past decades a huge interest in high hydrostatic pressure (HHP) technology is increasingly emerging among food and biosciences researchers. Microbial specific stress responses to HHP are currently being investigated, through the evaluation of pressure effects on biomolecules, cell structure, metabolic behavior, growth and viability. The knowledge development in this field allows a better comprehension of pressure resistance mechanisms acquired at sub-lethal pressures. In addition, new applications of HHP could arise from these studies, particularly in what concerns to biotechnology. For instance, the modulation of microbial metabolic pathways, as a response to different pressure conditions, may lead to the production of novel compounds with potential biotechnological and industrial applications. Considering pressure as an extreme life condition, this review intends to present the main findings so far reported in the scientific literature, focusing on microorganisms with the ability to withstand and to grow in high pressure conditions, whether they have innated or acquired resistance, and show the potential of the application of HHP technology for microbial biotechnology.     

“一带一路”沿线国家生物技术发展趋势研究

“一带一路”贯穿亚欧非大陆,联结活跃的东亚经济圈和发达的欧洲经济圈,以及中间经济发展潜力巨大的广大腹地国家与地区,“一带一路”战略将对中国未来国内外的政治、经济、文化、科技发展产生重大深远影响。本报告分析了“一带一路”沿线国家的科技发展基础条件,研究了“一带一路”沿线国家在生物技术领域取得的基础研究进展和专利技术研发进展的总体情况,综述了“一带一路”沿线国家生物技术产业发展现状和国际专利布局情况,并针对中国与“一带一路”沿线国家在生物技术领域进一步深化合作互利共赢提出了发展建议。     

Development of health biotechnology in developing countries: Can private-sector players be the prime movers?

Health biotechnology has rapidly become vital in helping healthcare systems meet the needs of the poor in developing countries. This key industry also generates revenue and creates employment opportunities in these countries. To successfully develop biotechnology industries in developing nations, it is critical to understand and improve the system of health innovation, as well as the role of each innovative sector and the linkages between the sectors. Countries' science and technology capacities can be strengthened only if there are non-linear linkages and strong interrelations among players throughout the innovation process; these relationships generate and transfer knowledge related to commercialization of the innovative health products. The private sector is one of the main actors in healthcare innovation, contributing significantly to the development of health biotechnology via knowledge, expertise, resources and relationships to translate basic research and development into new commercial products and innovative processes. The role of the private sector has been increasingly recognized and emphasized by governments, agencies and international organizations. Many partnerships between the public and private sector have been established to leverage the potential of the private sector to produce more affordable healthcare products. Several developing countries that have been actively involved in health biotechnology are becoming the main players in this industry. The aim of this paper is to discuss the role of the private sector in health biotechnology development and to study its impact on health and economic growth through case studies in South Korea, India and Brazil. The paper also discussed the approaches by which the private sector can improve the health and economic status of the poor.     

Environmental biotechnology: the ongoing quest

Environmental biotechnology, until now, has primarily focused on the development of technologies to treat aqueous, solid and gaseous wastes. At present, the basic knowledge on how biotechnology can handle these wastes has been acquired and the focus is now on the implementation of these processes as 'best available technology not entailing excessive costs' (BATNEEC) in the framework of strict and transparent environmental legislation. New environmental challenges continue to evolve, as it becomes clear that waste streams should be tackled in an overall holistic way. New technologies to reach this goal are currently under development. Novel aspects with respect to the domain of water treatment are, for example, the biomembrane reactor technology and the newly discovered processes to remove nitrogen by means of anaerobic ammonium oxidation. Also, most challenging is the continuing strive for re-use of treated wastewater. Indeed, water shortage is emerging in an increasing number of countries all over the world and necessitates the short cycling of water. Finally, biotechnology has a key role to play in the novel approaches to design wastewater treatment based on decentralised sanitation and reuse (DESAR). Solid waste is a major challenge worldwide. The implementation of anaerobic digestion to treat biowastes has become a grown-up technology. New approaches in which biotechnological processes are linked to physical processes, such as plasma technology, certainly deserve special attention for the coming decades. Soil and sediment clean up by means of biostimulation/remediation/augmentation is now well established. Certainly, a number of prospects need to be further explored, such as the use of special energy sources to stimulate in situ the microbial community and the seeding of knowledge to the in situ community by means of horizontal gene transfer mechanisms. A number of waste gases can be handled by biofilter systems. Biological treatment of wastegases is also evolving, inasmuch as that besides conventional chemical pollutants, now also highly problematic chemicals (even dioxins) can be dealt with through proper biotechnological approaches. A remarkable new potential is the use of well designed probiotics to upgrade aquaculture and together with conventional biological water treatment processes, to guarantee the overall water quality of this domain of food production.     

Life sciences and biotechnology in China

Life science and biotechnology have become a top priority in research and development in many countries as the world marches into the new century. China as a developing country with a 1.3 billion population and booming economy is actively meeting the challenge of a new era in this area of research. Owing to support from the government and the scientific community, and reform to improve the infrastructure, recent years have witnessed a rapid progress in some important fields of life science and biotechnology in China, such as genomics and protein sciences, neuroscience, systematics, super-hybrid rice research, stem cell and cloning technology, gene therapy and drug/vaccine development. The planned expansion and development of innovation in related sectors and the area of bioethics are described and discussed.     

Engineering Aspects of Carriers for Immobilized Biocatalysts

Global meat and milk consumption is exponentially increasing due to population growth, urbanization and changes in lifestyle in the developing world. This is an excellent opportunity for developing countries to improve the livestock sector by using technological advances. Biotechnology is one of the avenues for improved production in the “Livestock revolution”. Biotechnology developments applied to livestock health, nutrition, breeding and reproduction are improving with a reasonable pace in developing countries. Simple bio-techniques such as artificial insemination have been well implemented in many parts of the developing world. However, advanced technologies including transgenic plant vaccines, marker assisted selection, solid state fermentation for the production of fibrolytic enzymes, transgenic fodders, embryo transfer and animal cloning are confined largely to research organizations. Some developing countries such as Taiwan, China and Brazil have considered the commercialization of biotechnology in the livestock sector. Organized livestock production systems, proper record management, capacity building, objective oriented research to improve farmer’s income, collaborations with the developed world, knowledge of the sociology of an area and research on new methods to educate farmers and policy makers need to be improved for the creation and implementation of biotechnology advances in the livestock sector in the developing world.     

Development and enhancement of agricultural biotechnology in some countries in Latin America

A number of research institutions and both local and international agencles in Latin America are using biotechnology as part of an effort to enhance agricultural productivity. However, it is very much an open question as to whether all of these various organizations can provide the best means of realizing this goal. Latin American countries vary dramatically in their knowledge base and current use of modern biotechnology. Thus, while some countries lack the ability to develop, or possibly even implement, many aspects of modern biotechnology, others are quite advanced in this regard. This review provides a somewhat selective overview of current research in the area of agricultural biotechnology in Mexico, Costa Rica and Ecuador, with emphasis on how the existing agencies and institutions have responded to the challenge of biotechnology. In addition, general strategies for the development of agricultural biotechnology in these countries are presented and discussed.     

Bioethics and biotechnology

Biotechnology is at the intersection of science and ethics. Technological developments are shaped by an ethical vision, which in turn is shaped by available technology. Much in biotechnology can be celebrated for how it benefits humanity. But technology can have a darker side. Biotechnology can produce unanticipated consequences that cause harm or dehumanise people. The ethical implications of proposed developments must be carefully examined. The ethical assessment of new technologies, including biotechnology, requires a different approach to ethics. Changes are necessary because new technology can have a more profound impact on the world; because of limitations with a rights-based approach to ethics; because of the importance and difficulty of predicting consequences; and because biotechnology now manipulates humans themselves. The ethical questions raised by biotechnology are of a very different nature. Given the potential to profoundly change the future course of humanity, such questions require careful consideration. Rather than focussing on rights and freedoms, wisdom is needed to articulate our responsibilities towards nature and others, including future generations. The power and potential of biotechnology demands caution to ensure ethical progress.     

对生物医药产业可持续发展战略的思考

全球生物药品销售额以年均约30%的速度增长,大大高于全医药行业年均不到10%的增长速度,生物技术产业已不是几个国家的产业,而是一个全球化发展的产业,由于全球生态环境日益恶化,严重影响了各国发展的后劲,于是它们纷纷将发展生物技术产业作为可持续发展战略的一个重要内容。生物医药产业可持续发展是环境与发展战略的需要,其核心是技术创新,提出了生物医药产业可持续发展链和区域经济竞争力是促进生物医药产业可持续发展的基石,阐述了生物医药产业发展只有立足现实、谋划长远,紧抓发展优势,才能实现可持续发展战略目标。     

Case studies on the use of biotechnologies and on biosafety provisions in four African countries

This review is based on a study commissioned by the European Commission on the evaluation of scientific, technical and institutional challenges, priorities and bottlenecks for biotechnologies and regional harmonisation of biosafety in Africa. Biotechnology was considered within four domains: agricultural biotechnologies (‘Green’), industrial biotechnologies and biotechnologies for environmental remediation (‘White’), biotechnologies in aquaculture (‘Blue’) and biotechnologies for healthcare (‘Red’). An important consideration was the decline in partnerships between the EU and developing countries because of the original public antipathy to some green biotechnologies, particularly genetically modified organisms (GMOs) and food from GM crops in Europe. The study focus reported here was West Africa (Ghana, Senegal, Mali and Burkina Faso).The overall conclusion was that whereas high-quality research was proceeding in the countries visited, funding is not sustained and there is little evidence of practical application of biotechnology and benefit to farmers and the wider community. Research and development that was being carried out on genetically modified crop varieties was concentrating on improving food security and therefore unlikely to have significant impact on EU markets and consumers. However, there is much non-controversial green biotechnology such as molecular diagnostics for plant and animal disease and marker-assisted selection for breeding that has great potential application. Regarding white biotechnology, it is currently occupying only a very small industrial niche in West Africa, basically in the sole sector of the production of liquid biofuels (i.e., bio-ethanol) from indigenous and locally planted biomass (very often non-food crops). The presence of diffused small-scale fish production is the basis to develop and apply new (Blue) aquaculture technologies and, where the research conditions and the production sector can permit, to increase this type of production and the economy of this depressed areas. However, the problems bound to environmental protection must not be forgotten; priority should be given to monitor the risks of introduction of foreign species. Red biotechnologies potentially bring a vast domain of powerful tools and processes to achieve better human health, most notably improved diagnostics by molecular techniques, better targeting of pathogens and a better knowledge of their sensitivities to drugs to permit better treatment.Biosafety regulatory frameworks had been initiated in several countries, starting with primary biosafety law. However, disparate attitudes to the purpose of biosafety regulation (e.g., fostering informed decision-making versus ‘giving the green-light for a flood of GMOs’) currently prevent a needed consensus for sub-regional harmonisation. To date, most R&D funding has come from North America with some commercial interests from Asia, but African biotechnology workers expressed strong desire for (re-)engagement with interested parties from the European Union. Although in some of the visited countries there are very well qualified personnel in molecular biology and biosafety/regulation, the main message received is that human resources and capacity building in-house are still needed. This could be achieved through home-based courses and capacity-building including funds for post-degree research to motivate and retain trained staff.     

Climate Change and Its Adverse Impacts on Plant Growth in South Asia: Current Status and Upcoming Challenges

Socioeconomic development, adaptive capacity of the population, and demographic conditions across the states of South Asia make it more vulnerable to climate change. South Asia is daily going to be more vulnerable to climate change and climatic variability. This region is facing multiple challenges in terms of climate change, dilapidation of ecosystems, and food insecurity. Climate is the primary determining factor for agricultural output, which unswervingly influences food production across the globe. South Asia is mainly an agricultural foundation based region and thus the economy of these regions directly depends on agriculture and agricultural production. Due to the extensive dependence on natural assets for thriving, it makes the people of this region more vulnerable to climate change. This region is now under serious risk from sea-level rising and growing incidences of extreme events such as flash floods, enhanced temperature, drought, salinity, cyclones, storms, landslides, and irregularity of precipitation. These abiotic stresses continuously disturb plant growth and productivity. It is now the time to take urgent action on these issues towards a sustainable, inclusive and resource efficient way to overcome this. In this review, we summarize the overall situation of climate change in the South Asian countries and their adverse consequences on plants, and upcoming challenges towards a sustainable production.     

Trends in biotechnology: Sustainable technology development: From high tech to Eco Tech

Biotechnology as a multidisciplinary and transdisciplinary field of science and engineering is regarded to be a key technology for the future, able to essentially contribute to sustainable development. In the first part of this paper, a critical analysis of the status quo in biotechnologies is given in the area of pharmaceutical, agricultural, environmental, and industrial biotechnology as well as food biotechnology. Here the general potential becomes clear, but also a series of disadvantages which are partly the result of the existing paradigm in science and technology and partly in direct connection to bioprocessing itself. Nevertheless, these biotechnologies will contribute to sustainable development, but mainly in a shallow sense of survival and livelihood. In the second part of this paper, another new dimension in bioprocessing is elucidated, which is in agreement with the new ecological, holistic world view. Here the so-called “eco-principles” are derived from a systems analysis of the ecosphere and represent the intelligence of nature as the result of evolution. The eco-principles will serve as guidelines for the general eco-restructuring of technology, being a drastic change within the next 2–5 decades. For the applying of eco-principles, a quantitative measure for sustainability in technology was developed (“sustainable process index”), which will enable us to design the new technology paradigm called “Eco Tech”. Ecological security and social equity, together with economic efficiency will define sustainable technology development in a deeper sense. Following this route, a completely new dimension of biotechnology will be reached, where the technosphere is fully embedded into the natural cycles of the ecosphere on a local basis.     

Global Environmental Change and Population Health: Progress and Challenges

Escalating global environmental change (GEC) over the past century has been driven largely by rapid industrialization, population growth, overconsumption of natural resources, and associated waste disposal challenges, as well as the inappropriate uses of technology. These changes are already having and will increasingly continue to have significant impacts on human health and well-being. How to tackle these issues is an important challenge to scientists, policy-makers, and the general public. Scientific consensus now exists that GEC and population health are linked, even though the details and mechanisms underlying this link remain to be both explicated and quantified. In this article we provide an overview of progress and challenges in the area of GEC and population health since the late 1980s, highlighting some of the main landmarks in this area and recommending directions for future research.     

Developments in coffee biotechnology—in vitro plant propagation and crop improvement

Coffee is an important plantation crop grown in about 80 countries across the globe. In recent years, coffee attained lot of attention in the biotechnology research area. Since last three decades, there has been a steady flow of information on coffee biotechnology and now it is entering into the genomic era. Major milestones in coffee biotech research are successful in vitro manipulation and multiplication of coffee, development of gene transfer protocols and generation of transgenic coffee plants with specific traits. The isolation of genes involved in caffeine biosynthetic pathway has opened up new avenues for generating caffeine free transgenic coffee. With the initiation of international coffee genomics initiatives, the genomic research in coffee is expected to reach new dimensions. The IPR issues may play crucial role in sharing of benefits during international collaborations in near future. This review focuses on the basic and applied aspects of coffee biotechnology for newer potentials.     

Preparedness and international contribution on H5N1 highly pathogenic avian influenza and pandemic-influenza

Since the end of 2003, simultaneous outbreaks caused by H5N1 highly pathogenic avian influenza viruses (H5N1-HPAIV) occurred in poultries and in wild birds in the East Asia. The outbreaks are spreading now at least 48 countries in the Middle Eastern, African and European countries in addition to the East Asia. During the outbreaks, over 200 human infection cases with 55% fatality are confirmed at the moment and some human-to-human transmission in family clusters have been observed. The outbreaks are no more out of control and pandemic potential caused by H5N1-HPAIV is major concern. Therefore, it is urgently necessary to develop new diagnostic kits and effective vaccines and to stockpile anti-influenza drugs before pandemic alert period phase 4 defined by WHO. Furthermore, international supports to the affected countries for development and improvement of diagnostic system are required in the public health aspect.     

Transgenic plants as factories for biopharmaceuticals

Plants have considerable potential for the production of biopharmaceutical proteins and peptides because they are easily transformed and provide a cheap source of protein. Several biotechnology companies are now actively developing, field testing, and patenting plant expression systems, while clinical trials are proceeding on the first biopharmaceuticals derived from them. One transgenic plant-derived biopharmaceutical, hirudin, is now being commercially produced in Canada for the first time. Product purification is potentially an expensive process, and various methods are currently being developed to overcome this problem, including oleosin-fusion technology, which allows extraction with oil bodies. In some cases, delivery of a biopharmaceutical product by direct ingestion of the modified plant potentially removes the need for purification. Such biopharmaceuticals and edible vaccines can be stored and distributed as seeds, tubers, or fruits, making immunization programs in developing countries cheaper and potentially easier to administer. Some of the most expensive biopharmaceuticals of restricted availability, such as glucocerebrosidase, could become much cheaper and more plentiful through production in transgenic plants.     

Nuclear and mitochondrial phylogenies provide evidence for four species of Eurasian badgers (Carnivora)

Del Cerro, I., Marmi, J., Ferrando, A., Chashchin, P., Taberlet, P. & Bosch, M. (2010). Nuclear and mitochondrial phylogenies provide evidence for four species of Eurasian badgers (Carnivora). —Zoologica Scripta, 39, 415–425. The Eurasian badgers (Meles spp.) have a fairly widespread distribution in the Palearctic region and their great morphological variability throughout the vast geographic area has nourished an intense debate about the classification of this taxon. Therefore, the aim of this study was to clarify controversies in Eurasian badger taxonomy by means of a new molecular phylogeny. One‐hundred and seventeen individuals of Eurasian badgers from 18 countries throughout Eurasia were sequenced for up to 3257 bp of nuclear DNA over six loci (ACTC, BGN, CFTR, CHRNA1, TS and TTR) and 512 bp of the mitochondrial DNA control region. Statistical and phylogenetic analyses for combined nDNA, mtDNA and the total‐evidence data clearly showed a strong genetic differentiation in four well‐supported clades, three of which corresponded to allopatric badger species previously defined according to morphological data: Meles meles Linnaeus, 1758 in Europe; Meles leucurus Hodgson, 1847 in the continental part of Asia, except the south‐west part; and M. anakuma Temminck, 1844 in Japan. Up to now, the fourth clade, made up of individuals from south‐west Asia, had been considered as a subspecies. Supported by several pieces of morphological evidence, the new phylogeny revealed that it is necessary to revise the current taxonomic classification of Meles spp. and suggested that the badgers from south‐west Asia should be recognised as a separate species, being renamed M. canescens Blanford, 1875.     

现代生物技术与饲用微生态制剂

近年来,使用抗生素的副作用越来越多地受到关注,世界上许多国家已出台相应政策来控制抗生素的使用。但是由于养殖行业的迅猛发展,养殖密度加大,养殖动物病害发病的风险提高,急需可替代抗生素的新型绿色饲料添加剂产品。微生态制剂作为一种新型绿色饲料添加剂,在养殖行业发挥了重要作用。随着饲用微生态制剂产品研发的深入,现代生物技术在提升微生态制剂的理论和应用研究方面发挥着重要作用。PCR、核酸分子杂交、基因工程以及组学等技术已应用于微生物菌种鉴定、基因改良、作用机理等研究中。本文对饲用微生态制剂的研发现状进行了阐述,并综述了现代生物技术在饲用微生态制剂研究中的应用。